Literature DB >> 8968545

Endothelin-1-induced contraction in isolated aortae from normotensive and DOCA-salt hypertensive rats: effect of magnesium.

P Laurant1, A Berthelot.   

Abstract

1. The contractile responses to endothelin-1 and the effect on these of various magnesium concentrations, were studied in isolated aortic rings from normotensive Sprague-Dawley rats and deoxycorticosterone acetate-salt (DOCA-salt) hypertensive rats. 2. Contractions induced by endothelin-1 were smaller in endothelium-denuded aortae from DOCA-salt hypertensive rats than in those from normotensive rats. The absence of calcium in the medium attenuated endothelin-1-induced contractions of aortae from both normotensive and DOCA-salt rats, but the contraction was greater in aortae from DOCA-salt hypertensive rats. Ryanodine (which inhibits the release of intracellular calcium) inhibited endothelin-1-induced contractions in aortae from DOCA-salt hypertensive rats to a greater extent than in aortae from normotensive rats. 3. A high extracellular magnesium concentration (4.8 mM) attenuated endothelin-1-induced contractions in tissues from DOCA-salt hypertensive rats but not in tissues from normotensive rats. In the absence of calcium, a high concentration of magnesium attenuated endothelin-1-induced contraction in aortae from both normotensive and hypertensive rats. In the presence of ryanodine, a high concentration of magnesium did not modify the contraction in preparations from either strain. 4. Absence of magnesium attenuated endothelin-1-induced contractions in aortae from both normotensive and DOCA-salt hypertensive rats. In the absence of calcium, removal of magnesium totally inhibited endothelin-1-induced contraction in tissues from normotensive rats but had no effect in those from hypertensive rats. In the presence of ryanodine, the lack of magnesium inhibited endothelin-1-induced contractions in aortae from DOCA-salt hypertensive rats but increased the sensitivity to endothelin-1 of aortae from normotensive rats. 5. The presence of endothelium did not modify the effect of high magnesium on endothelin-1-induced contractions in aortae from normotensive and DOCA-salt hypertensive rats. Conversely, the attenuating effect of magnesium removal on endothelin-1-induced contractions did not occur when endothelium was present. 6. In conclusion, endothelin-1-induced contraction was blunted in aortae from DOCA-salt hypertensive rats. The blunted response was related to altered calcium utilization during contraction. Changes in extracellular magnesium concentration differentially alter endothelin-1-induced contraction in aortae from normotensive and hypertensive rats, possibly by interfering with calcium utilization during contraction. Magnesium may be required for the contractile response to endothelin-1 and increasing magnesium may limit the vascular effects of endothelin-1 in blood vessels from DOCA-salt hypertensive rats.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8968545      PMCID: PMC1915813          DOI: 10.1111/j.1476-5381.1996.tb16048.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  53 in total

1.  Effect of a nonselective endothelin antagonist on vascular remodeling in deoxycorticosterone acetate-salt hypertensive rats. Evidence for a role of endothelin in vascular hypertrophy.

Authors:  J S Li; R Larivière; E L Schiffrin
Journal:  Hypertension       Date:  1994-08       Impact factor: 10.190

2.  Magnesium sulphate reverses the carotid vasoconstriction caused by endothelin-I, angiotensin II and neuropeptide-Y, but not that caused by NG-nitro-L-arginine methyl ester, in conscious rats.

Authors:  P A Kemp; S M Gardiner; T Bennett; P C Rubin
Journal:  Clin Sci (Lond)       Date:  1993-08       Impact factor: 6.124

3.  Influence of endothelium on Mg(2+)-induced relaxation in noradrenaline-contracted aorta from DOCA-salt hypertensive rat.

Authors:  P Laurant; A Berthelot
Journal:  Eur J Pharmacol       Date:  1994-06-13       Impact factor: 4.432

Review 4.  Endothelin: potential role in hypertension and vascular hypertrophy.

Authors:  E L Schiffrin
Journal:  Hypertension       Date:  1995-06       Impact factor: 10.190

5.  Dietary magnesium supplementation modifies blood pressure and cardiovascular function in mineralocorticoid-salt hypertensive rats but not in normotensive rats.

Authors:  P Laurant; J P Kantelip; A Berthelot
Journal:  J Nutr       Date:  1995-04       Impact factor: 4.798

6.  High calcium diet effectively opposes the development of deoxycorticosterone-salt hypertension in rats.

Authors:  H Mäkynen; P Arvola; H Vapaatalo; I Pörsti
Journal:  Am J Hypertens       Date:  1994-06       Impact factor: 2.689

7.  Endothelin subtype B receptor-mediated calcium and contractile responses in small arteries of hypertensive rats.

Authors:  R M Touyz; L Y Deng; E L Schiffrin
Journal:  Hypertension       Date:  1995-12       Impact factor: 10.190

8.  Increased expression of endothelin-1 gene in blood vessels of deoxycorticosterone acetate-salt hypertensive rats.

Authors:  R Larivière; R Day; E L Schiffrin
Journal:  Hypertension       Date:  1993-06       Impact factor: 10.190

9.  Expression of endothelin-1 gene in blood vessels of adult spontaneously hypertensive rats.

Authors:  R Larivière; P Sventek; E L Schiffrin
Journal:  Life Sci       Date:  1995       Impact factor: 5.037

10.  Different effects of Mg2+ on endothelin-1- and 5-hydroxytryptamine-elicited responses in goat cerebrovascular bed.

Authors:  G Torregrosa; A J Perales; J B Salom; F J Miranda; M D Barberá; E Alborch
Journal:  J Cardiovasc Pharmacol       Date:  1994-06       Impact factor: 3.105

View more
  6 in total

1.  Association of hypermagnesemia and blood pressure in the critically ill.

Authors:  Leo A Celi; Daniel J Scott; Joon Lee; Rachel Nelson; Seth L Alper; Kenneth J Mukamal; Roger G Mark; John Danziger
Journal:  J Hypertens       Date:  2013-11       Impact factor: 4.844

2.  Endothelin-1-induced venous contraction is maintained in DOCA-salt hypertension; studies with receptor agonists.

Authors:  Stephanie W Watts; Gregory D Fink; Carrie A Northcott; James J Galligan
Journal:  Br J Pharmacol       Date:  2002-09       Impact factor: 8.739

3.  Magnesium and vascular changes in hypertension.

Authors:  Ana Rosa Cunha; Bianca Umbelino; Margarida L Correia; Mario Fritsch Neves
Journal:  Int J Hypertens       Date:  2012-02-29       Impact factor: 2.420

Review 4.  The Role of Magnesium in the Pathogenesis and Treatment of Glaucoma.

Authors:  Feyzahan Ekici; Şafak Korkmaz; Emine Esra Karaca; Sabahattin Sül; Hasan Ali Tufan; Bahri Aydın; Ergin Dileköz
Journal:  Int Sch Res Notices       Date:  2014-10-13

5.  The Influence of Two Different Doses of Magnesium Sulfate on Intraocular Pressure Variations after Injection of Succinylcholine and Endotracheal Intubation: A Prospective, Randomized, Parallel Three-Arm, Double-blind, Placebo-controlled Clinical Trial.

Authors:  Hany Mahmoud Yassin; Ahmed Tohamy Abdel Moneim; Ahmed Sherin Mostafa Bayoumy; Hasan Metwally Bayoumy; Sameh Galal Taher
Journal:  Anesth Essays Res       Date:  2017 Oct-Dec

Review 6.  Beneficial Role of Mg2+ in Prevention and Treatment of Hypertension.

Authors:  Andrea M P Romani
Journal:  Int J Hypertens       Date:  2018-06-11       Impact factor: 2.420

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.